ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
16.09
-0.37 (-2.25%)
Oct 13, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $793.36 million as of October 13, 2026. It is the 11,481st most valuable company in the world and the 2,385th biggest in the United States. Its market cap has decreased by 6.25% in one year.
Market Cap
793.36M
Enterprise Value
420.59M
1-Year Change
-6.25%
Global Rank
Country Rank
#2,385 United States
Category
ChartMarket Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $793.36M, an increase of 37.92%. That is a compound annual growth rate of 12.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 793.36M | -4.48% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jade Biosciences | 856.02M |
| SL Science Holding | 855.40M |
| Odyssey Therapeutics | 850.55M |
| Ginkgo Bioworks Holdings | 817.51M |
| SpyGlass Pharma | 815.46M |
| Arbutus Biopharma | 811.18M |
| Corvus Pharmaceuticals | 802.51M |
| Adlai Nortye Group | 785.01M |